Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients

International Journal of Cancer

Volumn 131, Issue 1, 2012, Pages 117-128

  Saeland, Eirikur ^a   Belo, Ana I ^a   Mongera, Sandra ^a   Van Die, Irma ^a   Meijer, Gerrit A ^a   Van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CEACAM5; colon carcinoma; DC SIGN; glycosylation; MGL; MUC1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CD209 ANTIGEN; CORE 1 ANTIGEN; GALECTIN 3; LECTIN; LEWIS Y ANTIGEN; MANNOSE; MUCIN 1; PEANUT AGGLUTININ; PLANT LECTIN; SIALYL LEWIS X ANTIGEN; THOMSEN FRIEDENREICH ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER GROWTH; CANCER TISSUE; COHORT ANALYSIS; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LECTIN BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; SIALYLATION;

ANTIGENS, CD15; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; COLON; COLONIC NEOPLASMS; GALECTIN 3; GASTRIC MUCOSA; GLYCOSYLATION; GPI-LINKED PROTEINS; HUMANS; INTESTINAL MUCOSA; LECTINS, C-TYPE; LEWIS BLOOD-GROUP SYSTEM; MANNOSE; MUCIN-1; PEANUT AGGLUTININ; RECEPTORS, CELL SURFACE;

EID: 84860214318     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26354     Document Type: Article

References (49)

1. van Kooyk Y, Rabinovich GA,. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol 2008; 9: 593-601.
2. Rovinoja A, Pujol FM, Hassinen A, Kellokumpu S,. Golgi pH, its regulation and roles in human disease. Ann Med 2011. [Epub ahead of print]. DOI: 10.3109/07853890.2011.579150.
3. Brooks SA,. The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol Histopathol 2000; 15: 143-58.
4. Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG,. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res 2005; 7: R780-R787.
5. Yin BW, Finstad CL, Kitamura K, Federici MG, Welshinger M, Kudryashov V, Hoskins WJ, Welt S, Lloyd KO,. Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int J Cancer 1996; 65: 406-12.
6. Sakamoto S, Watanabe T, Tokumaru T, Takagi H, Nakazato H, Lloyd KO,. Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 1989; 49: 745-52.
7. Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO,. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumours and normal tissue and in human tumour-derived cell lines. Cancer Res 1986; 46: 1553-61.
8. Nakayama T, Watanabe M, Katsumata T, Teramoto T, Kitajima M,. Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995; 75: 2051-6.
9. St Hill CA, Farooqui M, Mitcheltree G, Gulbahce HE, Jessurun J, Cao Q, Walcheck B,. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglucosaminyltrans ferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer 2009; 9: 79.
10. Lau KS, Dennis JW,. N-Glycans in cancer progression. Glycobiology 2008; 18: 750-60.
11. Saeland E, van Vliet SJ, Backstrom M, van den Berg V, Geijtenbeek TB, Meijer GA, van Kooyk Y,. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol Immunother 2007; 56: 1225-36.
12. van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB, van Kooyk Y,. Dendritic cells recognize tumour-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res 2005; 65: 5935-44.
13. Hammarstrom S,. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999; 9: 67-81.
14. Van Liempt E, Bank CM, Mehta P, Garcia-Vallejo JJ, Kawar ZS, Geyer R, Alvarez RA, Cummings RD, van Kooyk Y, van Die I,. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett 2006; 580: 6123-31.
15. Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, van Kooyk Y,. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003; 170: 1635-9.
16. Ho SB, Kim YS,. Carbohydrate antigens on cancer-associated mucin-like molecules. Semin Cancer Biol 1991; 2: 389-400.
17. Hollingsworth MA, Swanson BJ,. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004; 4: 45-60.
18. van Vliet SJ, Saeland E, van Kooyk Y,. Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol 2008; 29: 83-90.
19. Backstrom M, Link T, Olson FJ, Karlsson H, Graham R, Picco G, Burchell J, Taylor-Papadimitriou J, Noll T, Hansson GC,. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. Biochem J 2003; 376: 677-86.
20. van Stijn CM, van den Broek M, van de WR, Visser M, Tasdelen I, Tefsen B, van Die I,. Regulation of expression and secretion of Galectin-3 in human monocyte-derived dendritic cells. Mol Immunol 2009; 46: 3292-9.
21. Lis H, Sela BA, Sachs L, Sharon N,. Specific inhibition by N-acetyl- D -galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta 1970; 211: 582-5.
22. Lotan R, Skutelsky E, Danon D, Sharon N,. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 1975; 250: 8518-23.
23. Ito N, Nishi K, Kawahara S, Okamura Y, Hirota T, Rand S, Fechner G, Brinkmann B,. Difference in the ability of blood group-specific lectins and monoclonal antibodies to recognize the ABH antigens in human tissues. Histochem J 1990; 22: 604-14.
24. Yan L, Wilkins PP, varez-Manilla G, Do SI, Smith DF, Cummings RD,. Immobilized Lotus tetragonolobus agglutinin binds oligosaccharides containing the Le(x) determinant. Glycoconj J 1997; 14: 45-55.
25. Baldus SE, Thiele J, Park YO, Hanisch FG, Bara J, Fischer R,. Characterization of the binding specificity of Anguilla anguilla agglutinin (AAA) in comparison to Ulex europaeus agglutinin I (UEA-I). Glycoconj J 1996; 13: 585-90.
26. Kaku H, Van Damme EJ, Peumans WJ, Goldstein IJ,. Carbohydrate-binding specificity of the daffodil (Narcissus pseudonarcissus) and amaryllis (Hippeastrum hybr.) bulb lectins. Arch Biochem Biophys 1990; 279: 298-304.
27. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani EN, Wilson D,. Molecular cloning and expression of human tumour-associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286-93.
28. Cummings RD, Kornfeld S,. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J Biol Chem 1982; 257: 11230-4.
29. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, Leffler H, Smith DF, Cummings RD,. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 2008; 283: 10109-23.
30. Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM,. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest 1995; 95: 571-6.
31. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K, Narimatsu H,. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci USA 2005; 102: 4572-7.
32. Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM, Yu LG,. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer 2010; 9: 154.
33. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K, Rhodes JM,. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007; 282: 773-81.
34. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS,. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989; 49: 197-204.
35. Ohshio G, Imamura T, Imamura M, Yamabe H, Sakahara H, Nakada H, Yamashina I,. Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract. J Cancer Res Clin Oncol 1995; 121: 247-52.
36. van Vliet SJ, van Liempt E, Saeland E, Aarnoudse CA, Appelmelk B, Irimura T, Geijtenbeek TB, Blixt O, Alvarez R, van Die I, van Kooyk Y,. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumour antigens by dendritic cells. Int Immunol 2005; 17: 661-9.
37. Singh SK, Streng-Ouwehand I, Litjens M, Kalay H, Saeland E, van Kooyk Y,. Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. Int J Cancer 2011; 128: 1371-83.
38. Macao B, Johansson DG, Hansson GC, Hard T,. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat Struct Mol Biol 2006; 13: 71-6.
39. Fernandez-Rodriguez J, Dwir O, Alon R, Hansson GC,. Tumour cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions. Glycoconj J 2001; 18: 925-30.
40. Nichols EJ, Kannagi R, Hakomori SI, Krantz MJ, Fuks A,. Carbohydrate determinants associated with carcinoembryonic antigen (CEA). J Immunol 1985; 135: 1911-13.
41. Yamashita K, Totani K, Kuroki M, Matsuoka Y, Ueda I, Kobata A,. Structural studies of the carbohydrate moieties of carcinoembryonic antigens. Cancer Res 1987; 47: 3451-9.
42. Malagolini N, Santini D, Chiricolo M, Dall'Olio F,. Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. Glycobiology 2007; 17: 688-97.
43. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW,. Suppression of tumour growth and metastasis in Mgat5-deficient mice. Nat Med 2000; 6: 306-12.
44. Li D, Li Y, Wu X, Li Q, Yu J, Gen J, Zhang XL,. Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages. J Immunol 2008; 180: 3158-65.
45. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW, Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 1995; 130: 383-92.
46. Narasimhan S,. Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide β 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in β 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J Biol Chem 1982; 257: 10235-42.
47. Song Y, Aglipay JA, Bernstein JD, Goswami S, Stanley P,. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumour progression. Cancer Res 2010; 70: 3361-71.
48. Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den BF, Liu FT, Cardesa A, Campo E,. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997; 113: 1906-15.
49. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M,. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 1999; 15: 143-8.